Tumor size evaluated by pelvic examination compared with 3-D quantitative analysis in the prediction of outcome for cervical cancer.

PURPOSE Tumor size estimated by pelvic examination (PE) is an important prognostic factor in cervical cancer treated with radiation therapy (RT). Recent histologic correlation studies also showed that magnetic resonance (MR) imaging provides highly accurate measurements of the actual tumor volume. The purpose of this study was to: (a) compare the accuracy of PE and MR in predicting outcome, and (b) correlate tumor measurements by PE versus MR. METHODS AND MATERIALS Tumor measurements were performed prospectively in 43 patients with advanced cervical cancer. MR and PE were performed at the same time intervals: (a) at the start of RT, (b) after 20-24 Gy/2-2.5 weeks, (c) after 40-50 Gy/4-5 weeks, and (d) at follow-up (1-2 months after RT completion). PE measured tumor diameters in anteroposterior, lateral, and craniocaudal direction, and PE-derived tumor size was computed as maximum diameter, average diameter, and ellipsoid volume. MR-derived tumor size was calculated by summation of the tumor areas in each section and multiplication by the section thickness. Tumor regression during RT was calculated for each method as percentage of initial volume. The measurements were correlated with local failure and disease-free survival. Median follow-up was 29 months (range: 9-56 months). RESULTS Prediction of local control: Overall, tumor regression rate (rapid versus slow) was more precise than the initial tumor size in the prediction of outcome. MR provided a more accurate and earlier prediction of local control (at 2-2.5 weeks, and at 4-5 weeks of RT) than PE (only at follow-up). Based on the initial tumor size, MR was also better than PE in predicting disease-free survival and local control, particularly in large (> or = 100 cm3) tumors. Size correlation: Tumor size (maximum diameter, average diameter, volume) by PE and MR did not correlate well (r = 0.51, 0.61, and 0.58, respectively). When using MR measurements as a reference, PE tended to overestimate intermediate-size (40-99 cm3) tumors. CONCLUSION This preliminary study suggests that increased precision of tumor volume measurement leads to more accurate and earlier prediction of outcome in cervical cancer. MR tumor volumetry may be useful as an adjunct to PE in selected cases, and holds the potential to impact therapeutic decision-making.

[1]  J. van Nagell,et al.  The staging of cervical cancer: inevitable discrepancies between clinical staging and pathologic findinges. , 1971, American journal of obstetrics and gynecology.

[2]  D. Wazer,et al.  The influence of quantitative tumor volume measurements on local control in advanced head and neck cancer using concomitant boost accelerated superfractionated irradiation. , 1995, International journal of radiation oncology, biology, physics.

[3]  G. Fletcher,et al.  Guidelines for conservative hysterectomy after irradiation. , 1980, Gynecologic oncology.

[4]  P. Eifel,et al.  The relationship between brachytherapy dose and outcome in patients with bulky endocervical tumors treated with radiation alone. , 1994, International journal of radiation oncology, biology, physics.

[5]  H. Hricak,et al.  Editorial on "The influence of tumor size and morphology on the outcome of patients with FIGO stage IB squamous cell carcinoma of the uterine cervix". , 1994, International journal of radiation oncology, biology, physics.

[6]  V. Marcial,et al.  Radiation-induced tumor regression in carcinoma of the uterine cervix: prognostic significance. , 1970, The American journal of roentgenology, radium therapy, and nuclear medicine.

[7]  H D Thames,et al.  The tumor volume and clonogen number relationship: tumor control predictions based upon tumor volume estimates derived from computed tomography. , 1995, International journal of radiation oncology, biology, physics.

[8]  W. Hoskins,et al.  Staging of cervical cancer. , 1975, Clinical obstetrics and gynecology.

[9]  H. Hricak,et al.  Invasive cervical carcinoma: comparison of MR imaging and surgical findings. , 1988, Radiology.

[10]  W. Mendenhall,et al.  Stage IB or IIA-B carcinoma of the intact uterine cervix treated with irradiation: a multivariate analysis. , 1992, International journal of radiation oncology, biology, physics.

[11]  F. Ebner,et al.  Magnetic resonance imaging in cervical cancer: a basis for objective classification. , 1989, Gynecologic oncology.

[12]  H. Homesley,et al.  Relationship of lesion size to survival in patients with stage IB squamous cell carcinoma of the cervix uteri treated by radiation therapy. , 1980, Surgery, gynecology & obstetrics.

[13]  M. Anderson,et al.  Staging of carcinoma of the uterine cervix: MRI-surgical correlation. , 1989, Clinical radiology.

[14]  H. Hricak,et al.  Cancer of the uterus: the value of MRI pre- and post-irradiation. , 1991, International journal of radiation oncology, biology, physics.

[15]  P. Grigsby,et al.  Effect of tumor size on the prognosis of carcinoma of the uterine cervix treated with irradiation alone , 1992, Cancer.

[16]  F. Bova,et al.  Prognostic and treatment factors affecting pelvic control of stage ib and iia‐b carcinoma of the intact uterine cervix treated with radiation therapy alone , 1984, Cancer.

[17]  W T Yuh,et al.  Cervical cancer: application of MR imaging in radiation therapy. , 1993, Radiology.

[18]  V Gildengorin,et al.  Carcinoma of the cervix: predictive value of clinical and magnetic resonance (MR) imaging assessment of prognostic factors. , 1993, International journal of radiation oncology, biology, physics.

[19]  L Axel,et al.  Tumor recurrence versus fibrosis in the female pelvis: differentiation with MR imaging at 1.5 T. , 1988, Radiology.

[20]  C. Belloni,et al.  Carcinoma of the cervix: value of MR imaging in detecting parametrial involvement. , 1991, AJR. American journal of roentgenology.

[21]  H. Hricak,et al.  Cervical Carcinoma: Computed Tomography and Magnetic Resonance Imaging for Preoperative Staging , 1995, Obstetrics and gynecology.

[22]  P. Grigsby,et al.  The effect of volume of disease in patients with carcinoma of the uterine cervix. , 1991, International journal of radiation oncology, biology, physics.

[23]  J C Ehrhardt,et al.  Usefulness of tumor volumetry by magnetic resonance imaging in assessing response to radiation therapy in carcinoma of the uterine cervix. , 1996, International journal of radiation oncology, biology, physics.

[24]  F. Bova,et al.  Carcinoma of the intact uterine cervix, stage 1B-IIA-B, ≥6 cm in diameter: Irradiation alone vs preoperative irradiation and surgery☆ , 1985 .

[25]  L. Delclos,et al.  Bulky endocervical carcinoma: a 23-year experience. , 1992, International journal of radiation oncology, biology, physics.

[26]  G. Fletcher,et al.  ANALYSIS OF CENTRAL RECURRENT DISEASE IN STAGES I AND II SQUAMOUS CELL CARCINOMAS OF THE CERVIX ON INTACT UTERUS , 1969 .

[27]  J. Hong,et al.  Prognostic assessment of tumor regression after external irradiation for cervical cancer. , 1992, International journal of radiation oncology, biology, physics.

[28]  F. Ebner,et al.  Magnetic resonance imaging in cervical carcinoma: diagnosis, staging, and follow-up. , 1994, Magnetic resonance quarterly.

[29]  J. van Nagell,et al.  Radiation‐induced tumor regression as a prognostic factor in patients with invasive cervical cancer , 1982, Cancer.

[30]  J. Wharton,et al.  The influence of tumor size and morphology on the outcome of patients with FIGO stage IB squamous cell carcinoma of the uterine cervix. , 1994, International journal of radiation oncology, biology, physics.

[31]  D. Rubens,et al.  Stage IB cervical carcinoma: comparison of clinical, MR, and pathologic staging. , 1988, AJR. American journal of roentgenology.

[32]  J. Webster,et al.  The prognostic significance of tumor response during radiotherapy in cervical carcinoma. , 1973, Radiology.

[33]  W. Mendenhall,et al.  Can pretreatment computed tomography findings predict local control in T3 squamous cell carcinoma of the glottic larynx treated with radiotherapy alone? , 1993, International journal of radiation oncology, biology, physics.